Accuray Inc.
- ARAY ยท Nasdaq
- Surgical & Medical Instruments & Apparatus
- Madison, WI
- 809 employees
- CIK 0001138723
Updated from SEC filings through
Top things to know
Executives
-
Steve La Neve President and Chief Executive Officer of Accuray 8-K, 2026-11-04 - Chief Executive Officer Chief Executive Officer 10-K, 2026-08-27
- Neve Stephen R. La CEO 4, 2025-12-02
-
Ali Pervaiz SVP Chief Financial Officer 4, 2025-12-02 - Chief Information and Security Officer Chief Information and Security Officer 10-K, 2026-08-27
- Deputy Chief Information Security Officer Deputy Chief Information Security Officer 10-K, 2026-08-27
What leadership is saying
“As I said on our last call, fiscal 2026 was a year of transformation, and fiscal 2027 is about execution”
Earnings press release (8-K Ex. 99.1), filed November 4, 2026
Accuray Inc is a U.S. public company in surgical & medical instruments & apparatus (SIC 3841), headquartered in Madison, WI. It trades as ARAY on Nasdaq. Revenue was $402M in the fiscal year ending June 30, 2026, -12.3% from the year before. It reported about 809 employees. Steve La Neve is President and Chief Executive Officer of Accuray.
Five-year financials
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | $402M 10-K, 2026-08-27 | $459M 10-K, 2026-08-27 | $447M 10-K/A, 2026-02-17 | $448M 10-K, 2024-09-19 | $430M 10-K, 2024-09-19 |
| Operating income | -$26.4M 10-K, 2026-08-27 | $7.8M 10-K, 2026-08-27 | $504K 10-K/A, 2026-02-17 | $2.4M 10-K, 2024-09-19 | $8.1M 10-K, 2024-09-19 |
| SG&A | $84.0M 10-K, 2026-08-27 | $91.2M 10-K, 2026-08-27 | $92.7M 10-K/A, 2026-02-17 | $94.4M 10-K, 2024-09-19 | $94.1M 10-K, 2024-09-19 |
| Net income | -$49.2M 10-K, 2026-08-27 | -$1.6M 10-K, 2026-08-27 | -$15.5M 10-K/A, 2026-02-17 | -$9.3M 10-K, 2024-09-19 | -$5.3M 10-K, 2024-09-19 |
Annual figures from XBRL in each company's own filings. Click a figure to open the filing. SG&A marked derived is general and administrative plus selling and marketing.
Leadership and board
| Name | Title | Source |
|---|---|---|
| Steve La Neve | President and Chief Executive Officer of Accuray | 8-K, 2026-11-04 |
| Chief Executive Officer | Chief Executive Officer | 10-K, 2026-08-27 |
| Neve Stephen R. La | CEO | 4, 2025-12-02 |
| Ali Pervaiz | SVP Chief Financial Officer | 4, 2025-12-02 |
| Paul Miele | Named in proxy bio: Senior Vice President, Chief Commercial Officer | DEF 14A, 2026-10-16 |
| Chief Information and Security Officer | Chief Information and Security Officer | 10-K, 2026-08-27 |
| Deputy Chief Information Security Officer | Deputy Chief Information Security Officer | 10-K, 2026-08-27 |
| Paul Michael Miele | SVP, Chief Commercial Officer | 4, 2026-05-29 |
| Leonel Peralta | SVP, Chief Operations Officer | 4, 2026-03-03 |
| Michael John Murphy | VP, Corporate Controller | 4, 2025-11-03 |
| Chan W. Galbato | Named in proxy bio: Senior Advisor | DEF 14A, 2025-10-01 |
| Jesse Chew | Executive Employment Agreement | 10-K, 2025-08-28 |
| Michael Hoge | Separation Agreement and General Release | 10-K, 2025-08-28 |
| James M. Hindman | Board member (per proxy) bio: Director | DEF 14A, 2026-10-16 |
| Joseph E. Whitters | Board member (per proxy) bio: Director | DEF 14A, 2026-10-16 |
 Richard A. Meier | Director | 8-K, 2026-10-06 |
What Accuray Inc does
Accuray Incorporated is a radiation therapy company that develops, manufactures, sells and supports treatment delivery, planning, imaging and data management solutions designed to help clinical teams deliver precise radiation treatments across a broad range of clinical cases. Our portfolio includes the CyberKnife robotic platform and a differentiated helical portfolio that includes the Accuray Stellar, Radixact, Accuray Helix and Tomo C Systems, where available.
Shares and governance
| Shares outstanding | 120.2 million (as of October 31, 2026) | 10-Q, November 6, 2026 |
|---|---|---|
| Public float | $86.9M (as of December 31, 2025) | 10-K, August 27, 2026 |
| Reportable segments | 1 (period ending September 30, 2026) | 10-Q, November 6, 2026 |
| Latest proxy statement | Meeting November 19, 2026 (filed October 16, 2026) | DEF 14A, October 16, 2026 |
| Auditor | Grant Thornton LLP (San Jose, California) | Latest 10-K |
Insider trades
Open-market buys and sales by officers and directors, from Forms 4 and 5. One row per filing.
| Date | Insider | Trade | Shares | Value | Source |
|---|---|---|---|---|---|
| February 20, 2026 | Steven F. Mayer Director | Buy | 54,875 | $31K | Form 4, February 23, 2026 |
| February 19, 2026 | Steven F. Mayer Director | Buy | 195,125 | $103K | Form 4, February 20, 2026 |
| November 19, 2025 | Neve Stephen R. La CEO | Buy | 20,000 | $19K | Form 4, November 19, 2025 |
Recent 8-K events
- 8-K filed 2026-11-04
- Item 8.01 Other events
- 8-K filed 2026-11-04
- Item 2.02 Results of operations and financial condition (earnings release)
- Item 7.01 Regulation FD disclosure
- 8-K filed 2026-10-13
- Item 5.02 Departure or appointment of directors or officers; compensation
- 8-K filed 2026-10-06
- Item 5.02 Departure or appointment of directors or officers; compensation
- Item 5.07 Submission of matters to a vote of security holders
- Item 8.01 Other events
- 8-K filed 2026-08-19
- Item 2.02 Results of operations and financial condition (earnings release)
- Item 7.01 Regulation FD disclosure
- 8-K filed 2026-08-06
- Item 3.01 Notice of delisting or failure to meet listing standards
- 8-K filed 2026-07-29
- Item 1.01 Entry into a material definitive agreement
- Item 3.02 Unregistered sales of equity securities
- Item 5.02 Departure or appointment of directors or officers; compensation
- Item 8.01 Other events
- 8-K filed 2026-06-04
- Item 1.02 Termination of a material definitive agreement
- Item 7.01 Regulation FD disclosure
- 8-K filed 2026-05-06
- Item 2.02 Results of operations and financial condition (earnings release)
- Item 7.01 Regulation FD disclosure
- 8-K filed 2026-04-28
- Item 5.02 Departure or appointment of directors or officers; compensation
Frequently asked questions about Accuray Inc
- What does Accuray Inc do?
- In its own words, from Item 1 of its 10-K: "Accuray Incorporated is a radiation therapy company that develops, manufactures, sells and supports treatment delivery, planning, imaging and data management solutions designed to help clinical teams deliver precise radiation treatments across a broad range of clinical cases. Our portfolio includes the CyberKnife robotic platform and a differentiated helical portfolio that includes the Accuray Stellar, Radixact, Accuray Helix and Tomo C Systems, where available."
- What is Accuray Inc's revenue?
- $402M for the fiscal year ending June 30, 2026, from its 10-K filed August 27, 2026.
- Is Accuray Inc profitable?
- Accuray Inc reported net income of -$49.2M for the fiscal year ending June 30, 2026.
- How many employees does Accuray Inc have?
- About 809 as of June 30, 2026, as stated in its annual report.
- Who is the CEO of Accuray Inc?
- Steve La Neve, President and Chief Executive Officer of Accuray, as named in a 8-K filed November 4, 2026.
- Who is the CFO of Accuray Inc?
- Ali Pervaiz, SVP Chief Financial Officer, as named in a 4 filed December 2, 2025.
- Where is Accuray Inc headquartered?
- Madison, WI.
- What is Accuray Inc's stock ticker?
- ARAY on Nasdaq.
- What industry is Accuray Inc in?
- Surgical & Medical Instruments & Apparatus, SIC code 3841.
- What is Accuray Inc's website?
- accuray.com.
- When does Accuray Inc report earnings next?
- February 3, 2027. Source: estimate_8k_pattern.
- Is Accuray Inc a public company?
- Yes. Accuray Inc files with the SEC under CIK 0001138723 and trades as ARAY.
- Who audits Accuray Inc?
- Grant Thornton LLP, San Jose, California, as named in its latest annual report (10-K).
- How many shares of Accuray Inc are outstanding?
- 120.2 million shares as of October 31, 2026, from its 10-Q filed November 6, 2026.
- What is Accuray Inc's public float?
- $86.9M as of December 31, 2025, as reported on the cover of its 10-K filed August 27, 2026.
- How many business segments does Accuray Inc report?
- 1 reportable segment for the period ending September 30, 2026, from its 10-Q filed November 6, 2026.
- When is Accuray Inc's annual shareholder meeting?
- November 19, 2026, per its proxy statement (DEF 14A) filed October 16, 2026.
- Have Accuray Inc insiders traded stock recently?
- Since November 19, 2025, officers and directors reported 0 open-market sales and 3 purchases worth about $154K on Forms 4 and 5. The most recent: Steven F. Mayer (Director) bought 54,875 shares on February 20, 2026.